Trials / Completed
CompletedNCT06808802
To Investigate the Effect of Retatrutide (LY3437943) on Metoprolol Pharmacokinetics in Healthy Participants
A Phase 1, Open-label, Single-arm Study to Investigate the Effect of Retatrutide on Metoprolol Pharmacokinetics in Healthy Participants
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- Eli Lilly and Company · Industry
- Sex
- All
- Age
- 21 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study J1I-MC-GZQE is to measure the effect of retatrutide on the pharmacokinetics (PK) of metoprolol in healthy participants.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Retatrutide | Administered subcutaneously (SC) |
| DRUG | Metoprolol | Administered orally |
Timeline
- Start date
- 2025-02-03
- Primary completion
- 2025-04-15
- Completion
- 2025-04-15
- First posted
- 2025-02-05
- Last updated
- 2025-06-05
Locations
1 site across 1 country: Singapore
Source: ClinicalTrials.gov record NCT06808802. Inclusion in this directory is not an endorsement.